GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
Information
トップページ
Information
All
2026
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2008/06/24
The 7th Annual General Shareholder Meeting
2008/06/19
GNI Signs Binding Term Sheet to Raise Capital
2008/06/18
GNI’s F647 Shows Positive Results in Phase ? Human Clinical Trial of Idiopathic Pulmonary Fibrosis
2008/05/29
Global R&D Congress
2008/05/26
Financial Results Briefing for the fiscal year ended March 31, 2008
2008/05/20
GNI Announces Donation to Earthquake Area of China
2008/05/19
GNI Signs Term Sheet to Acquire Hengshan Pharmaceuticals of Shanghai, China
2008/05/16
China Patent and Trade Mark Office Grants Patent for RX50, a Drug Target Implicated in Human Cancers and Neurodegenerative Disorders
2008/05/15
Amount and Details of Stock Options as Remuneration for Directors and Corporate Auditors
2008/05/15
Notice of the candidates of Directors and Corporate Auditors
<
28
29
30
31
32
33
34
35
36
>